Learning Objectives for this course:

·  To understand the prostate patient’s journey from suspected cancer to the advanced disease state using the framework of de nable clinical states.
·  To know in detail the pathologic states, problems of categorisation and clinical needs of patients in each clinical state in the prostate cancer pathway.
·  To understand how imaging can help meet clinical priorities and so promote the personalisation of care in the advancing prostate cancer pathway.
·  To show how next generation prostate imaging (multiparametric MRI & MR-directed biopsies) and whole body assessments (whole body MRI & PET/CT) with clinical biomarkers, create opportunities to support and re ne management pathways of patients.